1. Home
  2. EVTC vs BHVN Comparison

EVTC vs BHVN Comparison

Compare EVTC & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Evertec Inc.

EVTC

Evertec Inc.

HOLD

Current Price

$31.38

Market Cap

1.8B

Sector

Technology

ML Signal

HOLD

Logo Biohaven Ltd.

BHVN

Biohaven Ltd.

HOLD

Current Price

$14.41

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EVTC
BHVN
Founded
1988
2013
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
2.0B
IPO Year
2013
2022

Fundamental Metrics

Financial Performance
Metric
EVTC
BHVN
Price
$31.38
$14.41
Analyst Decision
Hold
Buy
Analyst Count
5
14
Target Price
$35.80
$29.08
AVG Volume (30 Days)
382.6K
1.8M
Earning Date
05-06-2026
05-11-2026
Dividend Yield
0.67%
N/A
EPS Growth
27.17
26.08
EPS
0.47
N/A
Revenue
$453,869,000.00
N/A
Revenue This Year
$12.68
N/A
Revenue Next Year
$6.86
N/A
P/E Ratio
$64.70
N/A
Revenue Growth
11.48
N/A
52 Week Low
$21.81
$7.48
52 Week High
$37.38
$18.57

Technical Indicators

Market Signals
Indicator
EVTC
BHVN
Relative Strength Index (RSI) 58.40 51.98
Support Level $27.98 $13.84
Resistance Level $34.41 $17.01
Average True Range (ATR) 1.31 0.64
MACD -0.18 0.01
Stochastic Oscillator 46.43 72.50

Price Performance

Historical Comparison
EVTC
BHVN

About EVTC Evertec Inc.

Evertec Inc is a transaction processing business in Latin America and the Caribbean. Its business segments are Merchant Acquiring, Payment Services - Puerto Rico & Caribbean, Latin America Payments and Solutions, and Business Solutions. Latin America Payments and Solutions segment derive maximum revenue. The company serves a diversified customer base of financial institutions, merchants, corporations, and government agencies with mission-critical technology solutions that enable them to issue, process, and accept transactions securely. Geographically, it operates in Puerto Rico, Caribbean, and Latin America.

About BHVN Biohaven Ltd.

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder and others. Its pipeline products include: BHV-2000, BHV-7000, BHV-2100, BHV-8000, BHV-1310, BHV-1300, BHV-1400, BHV-1600, BHV-1530, and BHV-1500.

Share on Social Networks: